Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Vaginal microbiome of reproductive-age women
2010 Standout
Global Cancer in Women: Burden and Trends
2017
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 Standout
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns
2010 Standout
Human papillomavirus testing for primary screening of cervical cancer precursors.
2000
TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 16
2007
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Cervical Cancer Screening Among Adult Women in China, 2010
2015
Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP
2021 StandoutNobel
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
2001
Cancer statistics, 2020
2020 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial
2007
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China
2008
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 Standout
Prevention of cervical cancer through papillomavirus vaccination
2004
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
2004
The Pap Test and Bethesda 2014
2015
Computed Tomography — An Increasing Source of Radiation Exposure
2007 Standout
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies
2008
Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays—an update
2006
Expanding global access to radiotherapy
2015 Standout
Human papillomavirus and cervical cancer
2013
Cost-effectiveness studies of HPV self-sampling: A systematic review
2020
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
2010
A view on drug resistance in cancer
2019 StandoutNature
The epidemiology of human papillomavirus infections
2005
Visual inspection as a cervical cancer screening method in a primary health care setting in Africa
2006
Interactions between Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Type 1 Infection in African Women: Opportunities for Intervention
2000
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
2018
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study
2009
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
2000 Standout
Personal meaning of human papillomavirus and pap test results in adolescent and young adult women.
2007
Predicting absolute risk of CIN3 during post-colposcopic follow-up: Results from the ASCUS-LSIL Triage Study (ALTS)
2006
Recent observations on HIV type-1 infection in the genital tract of men and women
2003
Global Cancer Statistics, 2002
2005 Standout
Cancer burden in Africa and opportunities for prevention
2012
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
2010
Cost-effectiveness of Whole-Body CT Screening
2005
High‐risk HPV testing in women with borderline and mild dyskaryosis: long‐term follow‐up data and clinical relevance
2001
2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
2002
Aids-related malignancies
2002
Family history as a co‐factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: Results from two studies conducted in Costa Rica and the United States
2005
A Population‐Based Study of Vaginal Human Papillomavirus Infection in Hysterectomized Women
2004
The biology and management of non-small cell lung cancer
2018 StandoutNature
A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests
2005
Identifying Women With Cervical Neoplasia
1999
Human Papillomaviruses and Cervical Cancer in Bangkok. III. The Role of Husbands and Commercial Sex Workers
2001
Number of Cervical Biopsies and Sensitivity of Colposcopy
2006
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
2003
The role of human papillomavirus in cervical adenocarcinoma carcinogenesis
2001
Chapter 16: HPV vaccines in immunocompromised women and men
2006
Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test Results
2005
Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference
2001
Risk of High‐Grade Squamous Intraepithelial Lesion in HIV‐Infected Adolescents
2004
Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy
2003
Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial
2001
HPV infection in women with and without cervical cancer in Conakry, Guinea
2009
Human papillomavirus testing on self‐sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs
2007
The burden of non-communicable diseases in South Africa
2009 Standout
Chapter 19: Cost-effectiveness of cervical cancer screening
2006
Cervicovaginal Human Papillomavirus Infection in Human Immunodeficiency Virus-1 (HIV)-Positive and High-Risk HIV-Negative Women
1999
Chapter 5: Updating the natural history of HPV and anogenital cancer
2006
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
2002 Standout
Management of women who test positive for high-risk types of human papillomavirus: the HART study
2003
Human papillomavirus types among women infected with HIV: a meta-analysis
2006
The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC‐US or LSIL cervical cytology: A meta‐analysis of the diagnostic accuracy
2012
Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer
2012
Cost-effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined Significance
2002
The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
2005
Chapter 7: Achievements and limitations of cervical cytology screening
2006
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
2004
Skin Cancers after Organ Transplantation
2003 Standout
Epigenetics in Cancer
2008 Standout
Risk assessment to guide the prevention of cervical cancer
2007
Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology
2009
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
2001 StandoutScience
Chapter 11: Future Directions in Cervical Pathology
2003
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
2007
Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
2002
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study
2000
Global cancer statistics
2011 Standout
Population-based screening for cancer: hope and hype
2016
Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia
2004
Effects of Bacterial Vaginosis and Other Genital Infections on the Natural History of Human Papillomavirus Infection in HIV‐1–Infected and High‐Risk HIV‐1–Uninfected Women
2005
The role of sexually transmitted diseases in HIV transmission
2004 Standout
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Inflation of Sensitivity of Cervical Cancer Screening Tests Secondary to Correlated Error in Colposcopy
2005
A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica
2005
Detection of Hypermethylated Genes in Women with and Without Cervical Neoplasia
2005
The causal relation between human papillomavirus and cervical cancer
2002 Standout
The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence
2005
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
2006
Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus–Like Particles in Human Immunodeficiency Virus (HIV)–Positive and High‐Risk HIV–Negative Women
2003
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
2006
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
2012
Association between genital schistosomiasis and HIV in rural Zimbabwean women
2006
Human papillomavirus and cervical cancer
2007 Standout
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
A longitudinal study of HPV detection and cervical pathology in HIV infected women
2000
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
2006
The Natural History of Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Among Young Women in the Guanacaste Cohort Shortly After Initiation of Sexual Life
2007
Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection
2007
Risk factors of invasive cervical cancer in Mali
2002
Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities
2005
Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type
2007
Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition
2015
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
2015
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
2011 Standout
Cervical Cancer Screening Rates in the United States and the Potential Impact of Implementation of Screening Guidelines
2007
Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
2006
Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
2007
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Chapter 1: HPV in the etiology of human cancer
2006
Natural History and Possible Reactivation of Human Papillomavirus in Human Immunodeficiency Virus–Positive Women
2005
Progression of cervical lesions in HIV-seropositive women: A cytological study
2001
Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes
2006
Screening for Genital Human Papillomavirus
1999
Cancer incidence in a rural population of South Africa, 1998–2002
2010
Estimating the cost of cervical cancer screening in five developing countries.
2006
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
2012
A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion
2007
A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions
2000
Squamous cell carcinoma of the skin (excluding lip and oral mucosa)
1992
HPV Screening for Cervical Cancer in Rural India
2009
Chapter 6: Immunosuppression and Co-infection with HIV
2003
Chapter 10: New dimensions in cervical cancer screening
2006
Current methods of testing for human papillomavirus
2001
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years
2011
Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population‐based studies
2012
Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review
2006
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial
2006
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
2010 Standout
Serum Immunoglobulin G Response to Human Papillomavirus Type 16 Virus‐Like Particles in Human Immunodeficiency Virus (HIV)–Positive and Risk‐Matched HIV‐Negative Women
2003
Prevalence and Risk Factors for Anal Human Papillomavirus Infection in Human Immunodeficiency Virus (HIV)–Positive and High‐Risk HIV‐Negative Women
2001
DNA extraction: An understudied and important aspect of HPV genotyping using PCR-based methods
2007
The predicted impact of vaccination on human papillomavirus infections in Australia
2008
Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance
2002
Cost-effectiveness analyses of human papillomavirus vaccination
2007
Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent
2002
Cost-Effectiveness Analysis Based on the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)
2006
Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus
2003
A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India
2005
Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA
2000
The Burden of Human Papillomavirus Infections and Related Diseases in Sub-Saharan Africa
2013
Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women
1999
Photodetection of cervical intraepithelial neoplasia using 5-aminolevulinic acid-induced porphyrin fluorescence
2000
Control of Neglected Tropical Diseases
2007 Standout
Clinical utility of HPV–DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence
2005
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination
2006
Economic Evaluation of Human Papillomavirus Vaccination in Developed Countries
2009
Cervical screening adjuncts: Recent advances
1998
THERAPEUTIC APPROACHES TO PAPILLOMAVIRUS INFECTIONS
1997
ASCUS-LSIL Triage Study
2000
Association between cervical shedding of herpes simplex virus and HIV-1
2002
Human Papillomaviruses and Cervical Cancer in Bangkok. II. Risk Factors for in Situ and Invasive Squamous Cell Cervical Carcinomas
2001
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Cutaneous Squamous-Cell Carcinoma
2001 Standout
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
Deep Sequencing of the Vaginal Microbiota of Women with HIV
2010
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial
2007
Evidence-Based, Alternative Cervical Cancer Screening Approaches in Low-Resource Settings
2009
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
QUANTITATIVE OPTICAL SPECTROSCOPY FOR TISSUE DIAGNOSIS
1996
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Oral transmission of HIV
1998
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2007 Standout
Human Papillomavirus and Prognosis of Invasive Cervical Cancer: A Population-Based Study
2001
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults
1993 Standout
Cancer statistics in China, 2015
2016 Standout
Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America: This report refers to partial results from the LAMS (Latin AMerican Screening) study
2005
Persistence of Human Papillomavirus DNA in Benign and (Pre)malignant Skin Lesions from Renal Transplant Recipients
2000
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
2001
Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women
2006
Human Papillomavirus Testing Following Loop Electrosurgical Excision Procedure Identifies Women at Risk for Posttreatment Cervical Intraepithelial Neoplasia Grade 2 or 3 Disease
2006
Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review
2017
Human Papillomavirus Infection in Ulaanbaatar, Mongolia: A Population-Based Study
2008
Absolute autofluorescence spectra of human healthy, metaplastic, and early cancerous bronchial tissue in vivo
2001
Human Papillomavirus and Cervical Cancer
2003 Standout
Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy
2000
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
2020
Synergistically enhanced colorimetric molecular detection using smart cup: a case for instrument-free HPV-associated cancer screening
2019
The health and economic impact of scaling cervical cancer prevention in 50 low‐ and lower‐middle‐income countries
2017
Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent
2002
Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women
2007
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Two-Photon Absorbing Nanocrystal Sensors for Ratiometric Detection of Oxygen
2009 StandoutNobel
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
The Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus–Positive, Cytologically Normal Women Over a 10-Year Period
2006
Global cancer statistics, 2012
2015 Standout
Relationships of Human Papillomavirus Type, Qualitative Viral Load, and Age with Cytologic Abnormality
2006
Human Papillomavirus Testing for Triage of Women With Cytologic Evidence of Low-Grade Squamous Intraepithelial Lesions: Baseline Data From a Randomized Trial
2000
Age-Related Changes of the Cervix Influence Human Papillomavirus Type Distribution
2006
Prospects for the Future
2002 StandoutScienceNobel
Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions.
2003
Works of Thomas C. Wright being referenced
HPV DNA Testing of Self‐Collected Vaginal Samples Compared With Cytologic Screening To Detect Cervical Cancer
2001
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica
2003
The costs of reducing loss to follow-up in South African cervical cancer screening
2005
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
2007
Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women
1996
Evaluation of alternative methods of cervical cancer screening for resource-poor settings
2000
The Menstrual Cycle Does Not Affect Human Immunodeficiency Virus Type 1 Levels in Vaginal Secretions
2002
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
2015
Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries
2005
The carcinogenicity of human papillomavirus types reflects viral evolution
2005
Women's desired information about human papillomavirus
2004
Two-stage cervical cancer screening: An alternative for resource-poor settings
2000
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
2011
Screen-and-Treat Approaches for Cervical Cancer Prevention in Low-Resource Settings
2005
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening
2004
Cervical Precancer Detection Using a Multivariate Statistical Algorithm Based on Laser‐Induced Fluorescence Spectra at Multiple Excitation Wavelengths
1996
Controversies in the management of low‐grade cervical intraepithelial neoplasia
1993
Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and Italy
2005
The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results
2018
Bacterial Vaginosis and Susceptibility to HIV Infection in South African Women: A Nested Case‐Control Study
2005
A comparison of human papillomavirus testing of clinician‐collected and self‐collected samples during follow‐up after screen‐and‐treat
2010
Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology
2019
2001 Consensus Guidelines for the management of women with cervical intraepithelial neoplasia
2003
HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study
2002
Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears
1998
2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities
2002
Correlation between Human Immunodeficiency Virus Type 1 RNA Levels in the Female Genital Tract and Immune Activation Associated with Ulceration of the Cervix
2000
Dietary intake and blood levels of lycopene: Association with cervical dysplasia among non‐hispanic, black women
1998
Association Between Human Papillomavirus Type and Clonal Status of Cervical Squamous Intraepithelial Lesions
1996
Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test
1995
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine
2003
HPV DNA Testing for Cervical Cancer Screening
2006
Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource Settings
2001
Alternative approaches to cervical cancer screening for developing countries
2012
Conventional Cervical Cytologic Smears vs. ThinPrep Smears
1996
2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests
2007
HPV DNA Testing of Self-collected Vaginal Samples Compared With Cytologic Screening to Detect Cervical Cancer
2000
Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus
1997
Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration
2001
Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More
2004
Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis
1992
Direct visual inspection for cervical cancer screening
2002
Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource Settings
2000
Development of a multivariate statistical algorithm to analyze human cervical tissue fluorescence spectra acquired in vivo
1996
Role of human papillomavirus in the pathogenesis of genital tract warts and cancer
1990
Human Papillomavirus (HPV) Detection Among Human Immunodeficiency Virus–Infected Pregnant Thai Women: Implications for Future HPV Immunization
2006
Spectroscopic diagnosis of cervical intraepithelial neoplasia (CIN) in vivo using laser-induced fluorescence spectra at multiple excitation wavlengths
1996
Cervical ectopy and the transformation zone measured by computerized planimetry in adolescents
1999
HPV infections and cytologic abnormalities in vaccinated women 21–34 years of age: Results from the baseline phase of the Onclarity trial
2019
Correlation of Human Immunodeficiency Virus Type 1 RNA Levels in Blood and the Female Genital Tract
1999
Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus
1998
Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.
1994
Incidence of Cervical Squamous Intraepithelial Lesions in HIV-Infected Women
2000
Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population
2018
Reliability of the Xpert HPV Assay to Detect High-Risk Human Papillomavirus DNA in a Colposcopy Referral Population
2014
Cervical cancer screening in low‐resource settings: A cost‐effectiveness framework for valuing tradeoffs between test performance and program coverage
2015
Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
1998
Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
1998
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
2011
Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results
2011
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
2004
Interlaboratory variation in the performance of liquid-based cytology: Insights from the ATHENA trial
2013